Stay updated on Phakic ICL Multicenter Clinical Trial
Sign up to get notified when there's something new on the Phakic ICL Multicenter Clinical Trial page.

Latest updates to the Phakic ICL Multicenter Clinical Trial page
- ChecktodayChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page, indicating a document revision, with no changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedAdded a consolidated 'Locations' section listing study sites by state (Arizona, Hawaii, Indiana, Kansas, Maryland, Missouri, Nebraska, Ohio, Pennsylvania, South Dakota, Texas, Utah) and removed individual 'State Locations' headings; updated the page revision from v3.3.2 to v3.3.3 and removed the 'HHS Vulnerability Disclosure' link.SummaryDifference1%

- Check44 days agoChange DetectedFooter revision label updated from v3.3.1 to v3.3.2; no substantive changes to study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page footer now displays Revision: v3.3.1 instead of Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check58 days agoChange DetectedRemoved a government funding/operating-status notice from the page; the study details and eligibility information remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check72 days agoChange DetectedNo significant additions or deletions were detected in the page content. Any observed differences appear to be minor layout or timestamp updates that do not affect the core study information.SummaryDifference0.4%

Stay in the know with updates to Phakic ICL Multicenter Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phakic ICL Multicenter Clinical Trial page.